WallStreetZenWallStreetZen

NASDAQ: LXEO
Lexeo Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LXEO past revenue growth

How has LXEO's revenue growth performed historically?
Company
-100%
Industry
143.99%
Market
17.8%
LXEO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LXEO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

LXEO earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$66.4M
Current Profit Margin
0%

LXEO Return on Equity

Current Company
-22,855.1%
Current Industry
-63.5%
Current Market
188.7%
LXEO's Return on Equity (-22,855.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LXEO announces earnings.

LXEO Return on Assets

Current Company
-56.1%
Current Industry
2.9%
LXEO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LXEO Return on Capital Employed

Current Company
-54%
Current Industry
19.5%

LXEO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LXEO$0.00-$64.35M-$66.39M-100.00%N/A
TERN$0.00-$89.09M-$90.21M-100.00%N/A
AVIR$0.00-$134.52M-$135.96M-100.00%N/A
CRBU$34.48M-$96.30M-$102.07M+56.22%N/A
RVNC$234.04M-$290.64M-$323.99M+128.84%N/A
View Top Biotech Stocks

Lexeo Therapeutics Earnings & Revenue FAQ

What were LXEO's earnings last quarter?

On Invalid Date, Lexeo Therapeutics (NASDAQ: LXEO) reported Q4 2023 earnings per share (EPS) of $19.84, up 323.93% year over year. Total Lexeo Therapeutics earnings for the quarter were -$14.19 million. In the same quarter last year, Lexeo Therapeutics's earnings per share (EPS) was -$8.86.

If you're new to stock investing, here's how to buy Lexeo Therapeutics stock.

What was LXEO's earnings growth in the past year?

As of Q2 2024, Lexeo Therapeutics's earnings has grown year over year. Lexeo Therapeutics's earnings in the past year totalled -$66.39 million.

What was LXEO's revenue last quarter?

On Invalid Date, Lexeo Therapeutics (NASDAQ: LXEO) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Lexeo Therapeutics's revenue was $0.00.

What was LXEO's revenue growth in the past year?

As of Q2 2024, Lexeo Therapeutics's revenue has grown -100% year over year. This is 243.99 percentage points lower than the US Biotechnology industry revenue growth rate of 143.99%. Lexeo Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.